Internal Medicine, Medical Oncology · El Paso, TX
NPI
1477504611
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1900 N Oregon St, Ste 305
El Paso, TX, 79902
Phone (915) 225-2027
Groups this clinician bills Medicare through
Medicare paid, 2024
$332K
5,312 services
Medicare patients, 2024
320
Average age 73
Drug cost, 2024
$11.3M
2,867 prescriptions
Company payments, 2025
$2,804
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zening He was code 99214 (office e&m - established), 1,001 times for 211 patients. In total Zening He billed 5,312 services in 19 codes, and Medicare paid $332K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,001 | 211 | $90.50 | $91K |
| 99232 Hospital E&M - Subsequent | Facility | 806 | 119 | $56.47 | $46K |
| 99223 Hospital E&M - Initial | Facility | 94 | 94 | $124.28 | $12K |
| 96127 Behavioral Health Services | Office | 67 | 23 | $3.26 | $219 |
| 99205 Office E&M - New | Office | 58 | 58 | $153.55 | $8,906 |
| 99233 Hospital E&M - Subsequent | Facility | 45 | 29 | $85.03 | $3,826 |
| 76981 Ultrasound - Nonspecific | Office | 39 | 27 | $66.18 | $2,581 |
By year: 2022 $201K for 2,597 services; 2023 $247K for 2,728 services; 2024 $332K for 5,312 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zening He prescribed most often to Medicare patients was Eliquis (Apixaban), with 512 prescriptions and refills. In total Zening He wrote 2,867 Medicare prescriptions that cost $11.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 512 | 595 | 97 | $347K |
| Warfarin Sodium Generic | 133 | 254 | 31 | $1,022 |
| Xarelto Rivaroxaban | 98 | 146 | 24 | $81K |
| Levothyroxine Sodium Generic | 95 | 142 | 14 | $360 |
| Hydroxyurea Generic | 93 | 167 | 22 | $2,494 |
| Ondansetron Hcl Generic | 89 | 89 | 51 | $1,158 |
| Xtandi Enzalutamide | 88 | 88 | 11 | $1.3M |
| Anastrozole Generic | 74 | 160 | 17 | $824 |
| Potassium Chloride Generic | 65 | 75 | 23 | $334 |
| Revlimid Lenalidomide | 64 | 64 | 11 | $1.1M |
| Promacta Eltrombopag Olamine | 59 | 59 | Under 11 | $624K |
| Gabapentin Generic | 58 | 66 | 18 | $609 |
| Orgovyx Relugolix | 57 | 57 | Under 11 | $154K |
| Dexamethasone Generic | 52 | 77 | 15 | $1,132 |
| Fondaparinux Sodium Generic | 48 | 51 | Under 11 | $52K |
Brand drugs: 1,439 claims; generic drugs: 1,428 claims; opioid claims: 60.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zening He $2,804 ($2,804 in general payments such as food, travel and fees) from 26 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $469.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 20 | $469 |
| Janssen Biotech, Inc. JNJ | 18 | $370 |
| Astellas Pharma US Inc 4503.T | 18 | $334 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 16 | $247 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $237 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $199 |
| Pfizer Inc. PFE | 8 | $154 |
| Merck Sharp & Dohme LLC MRK | 7 | $143 |
| Exelixis Inc. EXEL | 4 | $66.42 |
| Servier Pharmaceuticals LLC | 2 | $62.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.